FDA Accepts ANDA for Choline Fenofibrate by Macleods Pharmaceuticals
The FDA has accepted the Abbreviated New Drug Application (ANDA) for Choline Fenofibrate submitted by Macleods Pharmaceuticals.
Therapeutic Area
Therapeutic area intelligence for Lipid Regulation with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.